Screening markers of impaired glucose tolerance in the obese pediatric population

Hormone Research in Paediatrics

Volumn 73, Issue 2, 2010, Pages 102-107

  Tsay, J ^a   Pomeranz, C ^b   Hassoun, A ^b   Zandieh, S O ^a   Rutledge, J ^a   Vogiatzi, M G ^a   Oberfield, S E ^b   Motaghedi, R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Medicine   (United States)

Author keywords

Childhood diabetes; Childhood obesity; Glucose intolerance; Hemoglobin A1c; Insulin resistance

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BLOOD PRESSURE; BODY MASS; CHEMOLUMINESCENCE; CHILD; DIET RESTRICTION; DISEASE MARKER; ENZYME MECHANISM; ETHNICITY; FAMILY HISTORY; FEMALE; GLUCOSE TOLERANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INFANT; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY; PREDICTOR VARIABLE; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCREENING;

ADOLESCENT; ADULT; ALGORITHMS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OBESITY; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77951263903     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000277625     Document Type: Article

References (28)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
2. Ogden CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents, 1999- 2000. JAMA 2002; 288: 1728-1732.
3. Acton KJ, Burrows NR, Moore K, Querec L, Geiss LS, Engelgau MM: Trends in diabetes prevalence among American Indian and Alaskan native children, adolescents, and young adults. Am J Publ Health 2002; 92: 1485-1490. (Pubitemid 34924953)
4. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P: Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996; 128: 608-615. (Pubitemid 26137717)
5. Likitmaskul S, Kiattisathavee P, Chaichanwatanakul K, Punnakanta L, Angsusingha K, Tuchinda C: Increasing prevalence of type 2 diabetes mellitus in Thai children and adolescents associated with increasing prevalence of obesity. J Pediatr Endocrinol Metab 2003; 16: 71-77 (Pubitemid 37259095)
6. Rosenbloom AL, Joe JR, Young RS, Winter WE: Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345-354.
7. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924. (Pubitemid 29241045)
8. Barrett-Connor E, Ferrara A: Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the Rancho Bernardo Study. Diabetes Care 1998; 21: 1236-1239. (Pubitemid 28365676)
9. Cali AM, Caprio S: Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? Curr Opin Endocrinol Diabetes Obes 2008; 15: 123-127. (Pubitemid 351651724)
10. American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care 2000; 23: 381-389. (Pubitemid 30131749)
11. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403. (Pubitemid 34437694)
12. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350. (Pubitemid 32378388)
13. Standards of medical care in diabetes - 2008. Diabetes Care 2008; 31(suppl 1):S12-S54.
14. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
15. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167. (Pubitemid 37339514)
16. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, Kronmal RA, Resnick HE, Psaty BM: Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 2002; 162: 209-216. (Pubitemid 34098191)
17. Baral N, Koner BC, Karki P, Ramaprasad C, Lamsal M, Koirala S: Evaluation of new WHO diagnostic criteria for diabetes on the prevalence of abnormal glucose tolerance in a heterogeneous Nepali population - the implications of measuring glycated hemoglobin. Singapore Med J 2000; 41: 264-267.
18. Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J: Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2005; 2: 67-72. (Pubitemid 40826998)
19. Geberhiwot T, Haddon A, Labib M: HbA1c predicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose. Ann Clin Biochem 2005; 42: 193-195. (Pubitemid 40694958)
20. Tabaei BP, Engelgau MM, Herman WH: A multivariate logistic regression equation to screen for dysglycaemia: development and validation. Diabet Med 2005; 22: 599-605.
21. Nelson KM, Boyko EJ: Predicting impaired glucose tolerance using common clinical information: data from the Third National Health and Nutrition Examination Survey. Diabetes Care 2003; 26: 2058-2062.
22. Puri M, Freeman K, Garcia M, Nussbaum H, Dimartino-Nardi JR: Criteria for oral glucose tolerance testing of obese minority youth. J Pediatr Endocrinol Metab 2007; 20: 703-709. (Pubitemid 47054625)
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
24. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410. (Pubitemid 32269192)
25. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-576. (Pubitemid 39006657)
26. Marshall WA, Tanner JM: Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
27. Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708-723. (Pubitemid 35013848)
28. Le Stunff C, Bougneres P: Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes 1994; 43: 696-702. (Pubitemid 24138784)